Tyra Biosciences (TYRA) Other Non-Current Assets (2020 - 2026)
Quarterly Other Non-Current Assets fell 11.6% to $884000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $884000.0 through Mar 2026, down 11.6% year-over-year, with the annual reading at $1.0 million for FY2025, 0.0% changed from the prior year.
Tyra Biosciences filings provide 7 years of Other Non-Current Assets readings, the most recent being $884000.0 for Q1 2026.
- Other Non-Current Assets hit $884000.0 in Q1 2026 for Tyra Biosciences, down from $1.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $11.1 million in Q2 2025 and bottomed at $362000.0 in Q1 2022.
- Average Other Non-Current Assets over 5 years is $2.2 million, with a median of $1.0 million recorded in 2022.
- The largest annual shift saw Other Non-Current Assets plummeted 82.96% in 2023 before it soared 1010.9% in 2025.
- Tyra Biosciences' Other Non-Current Assets stood at $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025, then fell by 11.6% to $884000.0 in 2026.
- Per Business Quant, the three most recent readings for TYRA's Other Non-Current Assets are $884000.0 (Q1 2026), $1.0 million (Q4 2025), and $1.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.13 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 884,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 884,000.00 |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 11.11 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 4.96 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 866,000.00 |
| Mar 31, 2023 | 3.87 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 5.08 Mn |
| Mar 31, 2022 | 362,000.00 |
| Dec 31, 2021 | 312,000.00 |
| Sep 30, 2021 | 318,000.00 |
| Dec 31, 2020 | 21,000.00 |